REG - Smith & Nephew Plc - Director/PDMR Shareholding

Smith & NephewAnnouncement

19/05/2023 16:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230519:nRSS0848Aa&default-theme=true

RNS Number : 0848A  Smith & Nephew Plc  19 May 2023

SMITH & NEPHEW PLC

 

19 May 2023

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE
EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

 Reason for the notification
 Initial notification /Amendment                              Initial notification
 Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 Name                                                         Smith & Nephew plc
 LEI                                                          213800ZTMDN8S67S1H61
 Details of the transaction(s): section to be repeated for (i) each type of
 instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted
 Description of the financial instrument, type of instrument  Smith & Nephew plc ordinary shares of USD 0.20 each

 Identification code                                          ISIN: GB0009223206
 Nature of the transaction                                    Purchase of ordinary shares through the Company's Dividend Re-Investment Plan
                                                              following the 2022 final dividend payment on 17 May 2023.
 Date of Transaction                                          2023 - 05 - 17
 Place of Transaction                                         London Stock Exchange (XLON)

 

 Name                                                            Director / PDMR  Price       Volume      Aggregated information  Total Ordinary Share Holding following the transaction *  Total Ordinary Share Holding as a % of the Company's ISC following the

                                                                                                                                                                                          transaction *
 (Position)
 Helen Barraclough                                               PDMR             £13.13964   406.16316   N/A Single Transaction  29,139.41087                                              0.00332%

 (Group General Counsel and Company Secretary)
 Bradley Cannon                                                  PDMR             £13.13964   365.26743   N/A Single Transaction  118,184.64237 (including 3,599.09977 in ADS')             0.01347%

 (Global Orthopaedics)
 Paul Connolly                                                   PDMR             £13.13964   102.08593   N/A Single Transaction  7,400.08593                                               0.00084%

 (President Global Operations)
 Phil Cowdy                                                      PDMR             £13.13964   195.14937   N/A Single Transaction  49,196.14246                                              0.00561%

 (Chief Corporate Development & Corporate Affairs Officer)
 Myra Eskes                                                      PDMR             £13.13964   855.60779   N/A Single Transaction  62,021.97554                                              0.00707%

 (President APAC & Global Service)
 Simon Fraser                                                    PDMR             £13.13964   707.85737   N/A Single Transaction  51,311.72617                                              0.00585%

 (President AWM and Global Commercial Operations)
 Mizanu Kebede                                                   PDMR             £13.13964   54.14835    N/A Single Transaction  5,530.80779 (including 802.82972 in ADS')                 0.00063%

 (Chief Quality & Regulatory Affairs Officer)
 Elga Lohler                                                     PDMR             £13.13964   285.19156   N/A Single Transaction  144,683.19156 (including 3,015.00000 in ADS')             0.01649%

 (Chief HR Officer)
 Deepak Nath                                                     Director         £13.13964   1,367.8228  N/A Single Transaction  99,151.82280                                              0.01130%

 (Chief Executive Officer)
 Vasant Padmanabhan                                              PDMR             £13.13964   264.13931   N/A Single Transaction  100,353.13931                                             0.01143%

 (President Research & Development)
 Alison Parkes                                                   PDMR             £13.13964   30.61803    N/A Single Transaction  4,679.11972 (including 1,040.32795 in ADS')               0.00053%

 (Chief Compliance Officer)
 Scott Schaffner                                                 PDMR             £13.13964   763.54875   N/A Single Transaction  68,095.98048 (including 1,927.12679 in ADS')              0.00776%

 (President Sports Medicine)

 

* including those held by Persons Closely Associated with the Director/PDMR.
All figures in these columns are stated to 5 decimal places where applicable.

 

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

 

Tel:  +44 (0)1923 477100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFESELIALIV